tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Nxera Completes Buyback and Consent Solicitation for Convertible Bonds
Company AnnouncementsNxera Completes Buyback and Consent Solicitation for Convertible Bonds
4d ago
Nxera Pharma Receives Dividends from UK Subsidiary
PremiumCompany Announcements
Nxera Pharma Receives Dividends from UK Subsidiary
6d ago
Nxera Pharma Initiates Bond Buyback and Consent Solicitation
PremiumCompany Announcements
Nxera Pharma Initiates Bond Buyback and Consent Solicitation
18d ago
Nxera Pharma Launches New Employee Stock Ownership Plan in Japan
PremiumCompany Announcements
Nxera Pharma Launches New Employee Stock Ownership Plan in Japan
25d ago
Nxera Pharma Announces Strategic Restructuring to Boost Profitability
PremiumCompany Announcements
Nxera Pharma Announces Strategic Restructuring to Boost Profitability
27d ago
Nxera Pharma Advances in Metabolic Therapies Amid Financial Challenges
PremiumCompany AnnouncementsNxera Pharma Advances in Metabolic Therapies Amid Financial Challenges
1M ago
SOLTF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SOLTF Upcoming Earnings Report: What to Expect?
2M ago
Nxera Pharma Achieves Key Milestone in AbbVie Collaboration
Premium
Company Announcements
Nxera Pharma Achieves Key Milestone in AbbVie Collaboration
3M ago
Nxera Pharma Advances Cancer Immunotherapy to Phase 2a Trial
PremiumCompany Announcements
Nxera Pharma Advances Cancer Immunotherapy to Phase 2a Trial
3M ago
Nxera Pharma Reports Revenue Growth Amid Net Loss
PremiumCompany Announcements
Nxera Pharma Reports Revenue Growth Amid Net Loss
4M ago
Nxera Pharma Reports Strong First Half 2025 Results and Strategic Advances
PremiumCompany Announcements
Nxera Pharma Reports Strong First Half 2025 Results and Strategic Advances
4M ago
Nxera Pharma Unveils New Obesity Treatment Pipeline
PremiumCompany Announcements
Nxera Pharma Unveils New Obesity Treatment Pipeline
4M ago
Nxera Pharma Secures $4.8 Million Milestone Payment from Centessa
PremiumCompany AnnouncementsNxera Pharma Secures $4.8 Million Milestone Payment from Centessa
5M ago
Nxera Pharma Receives $15 Million Milestone Payment as Phase 3 Schizophrenia Trial Begins
Premium
Company Announcements
Nxera Pharma Receives $15 Million Milestone Payment as Phase 3 Schizophrenia Trial Begins
6M ago
Nxera Pharma Reaches Key Milestone in Eli Lilly Collaboration
Premium
Company Announcements
Nxera Pharma Reaches Key Milestone in Eli Lilly Collaboration
7M ago
Nxera Pharma Reports Revenue Growth Amidst Losses
PremiumCompany Announcements
Nxera Pharma Reports Revenue Growth Amidst Losses
8M ago
Nxera Pharma Reports Strong Q1 2025 Results and Strategic Advances
PremiumCompany Announcements
Nxera Pharma Reports Strong Q1 2025 Results and Strategic Advances
8M ago
Nxera Pharma’s Schizophrenia Treatment Enters Phase 3 Trials
PremiumCompany Announcements
Nxera Pharma’s Schizophrenia Treatment Enters Phase 3 Trials
8M ago
Sosei Group Corporation (SOLTF) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Sosei Group Corporation (SOLTF) Q1 Earnings Cheat Sheet
8M ago
Nxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
PremiumCompany AnnouncementsNxera Pharma’s Partner Advances Phase 2 Trial for Alcohol Use Disorder Treatment
9M ago
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
Premium
Company Announcements
Nxera Pharma Assigns Cenerimod Rights to Viatris for Japan and APAC
10M ago
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
Premium
Company Announcements
Nxera Pharma Corrects Financial Notice on Capital Reserve and Surplus Disposition
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >